330 First-in-man study of gemcitabine hydrochloride oral formulation (D07001-F4) in patients with malignant tumors. (September 2015) - Gabrail, N.; Ghamande, S.; Silverman, M.; Smith, C.; Ho, H.L.; Huang, C.T.; Hsueh, S.P.; Lin, C.L.